High-Dose Chemotherapy for Small Cell Lung Cancer

[1]  E. Vries,et al.  No narcosis for bone marrow harvest in autologous bone marrow transplantation , 1984, Blut.

[2]  P. Postmus,et al.  Remission of brain metastases from small-cell lung cancer after high-dose chemotherapy. , 1984, Annals of internal medicine.

[3]  E. de Vries,et al.  Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study. , 1984, European journal of cancer & clinical oncology.

[4]  P. Postmus,et al.  Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  N. Mulder,et al.  Small cell lung cancer and the influence of chemotherapy on CFUcs in bone marrow , 1984, Cancer.

[6]  F. Appelbaum,et al.  Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. , 1983, Cancer treatment reports.

[7]  J. Fay,et al.  Intensive 1,3‐bis(2‐chloroethyl)‐1‐nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer a phase I‐II study , 1983, Cancer.

[8]  J. Hainsworth,et al.  High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Jameson Ch,et al.  Stevens-Johnson syndrome associated with etoposide therapy. , 1983 .

[10]  M. Valdivieso,et al.  High‐dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma , 1983, Cancer.

[11]  P. Biron,et al.  Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis. , 1983, European journal of cancer & clinical oncology.

[12]  J. Hainsworth,et al.  High-dose etoposide as single-agent chemotherapy for small cell carcinoma of the lung. , 1983, Cancer treatment reports.

[13]  I. Smith,et al.  High-dose cyclophosphamide (7 g/m2) with or without autologous bone marrow rescue after conventional chemotherapy in the treatment of patients with small cell lung cancer. , 1983, Cancer treatment reviews.

[14]  N. Gorin,et al.  Delayed kinetics of recovery of haemopoiesis following autologous bone marrow transplantation. The role of excessively rapid marrow freezing rates after the release of fusion heat. , 1983, European journal of cancer & clinical oncology.

[15]  J. Pontes,et al.  High-dose cytoreductive therapy with autologous bone marrow transplantation in advanced malignancies. , 1983, Cancer treatment reports.

[16]  F. Greco,et al.  Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer. , 1982, The American journal of medicine.

[17]  J. Klastersky,et al.  Cisplatin, adriamycin, and etoposide (cav) for remission induction of small‐cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone‐marrow rescue , 1982, Cancer.

[18]  J. Minna,et al.  Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lung. , 1982, Cancer treatment reports.

[19]  R. Gale,et al.  High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer. , 1981, The American journal of medicine.

[20]  R. Weiss,et al.  The nitrosoureas and pulmonary toxicity. , 1981, Cancer treatment reviews.

[21]  J. Gottdiener,et al.  Cardiotoxicity associated with high-dose cyclophosphamide therapy. , 1981, Archives of internal medicine.

[22]  F. Hirsch,et al.  Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. , 1980, Cancer research.

[23]  I. Smith,et al.  PREVENTION OF ISOPHOSPHAMIDE-INDUCED UROTHELIAL TOXICITY WITH 2-MERCAPTOETHANE SULPHONATE SODIUM (MESNUM) IN PATIENTS WITH ADVANCED CARCINOMA , 1980, The Lancet.

[24]  R. Abrams,et al.  HÆMOPOIETIC RECOVERY IN EWING'S SARCOMA AFTER INTENSIVE COMBINATION THERAPY AND AUTOLOGOUS MARROW INFUSION , 1980, The Lancet.

[25]  G. Spitzer,et al.  High‐dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors , 1980, Cancer.

[26]  D. Sleijfer,et al.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. , 1980, European journal of cancer.

[27]  R. Bast,et al.  High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. , 1980, The American journal of medicine.

[28]  A. Zander,et al.  The myeloid progenitor cell--its value in predicting hematopoietic recovery after autologous bone marrow transplantation. , 1980, Blood.

[29]  P. Neiman,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.

[30]  A. Zander,et al.  High-dose BCNU therapy with autologous bone marrow infusion: preliminary observations. , 1979, Cancer treatment reports.

[31]  D. Hedley,et al.  Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan. , 1979, British Journal of Cancer.

[32]  F. Greco,et al.  Small-cell lung cancer , 1979, Cancer Chemotherapy and Pharmacology.

[33]  J. Minna,et al.  Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis , 1979 .

[34]  F. Appelbaum,et al.  Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma , 1978 .

[35]  R. Weiss.  Small-cell carcinoma of the lung: therapeutic management. , 1978, Annals of internal medicine.

[36]  F. Appelbaum,et al.  Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse , 1978, Cancer.

[37]  Martin H. Cohen,et al.  Treatment of bronchogenic carcinoma , 1977 .

[38]  J. Minna,et al.  Intensive chemotherapy of small cell bronchogenic carcinoma. , 1977, Cancer treatment reports.

[39]  R. Weiner,et al.  Cryopreserved autologous marrow infusion following high dose cancer chemotherapy. , 1977, European journal of cancer.

[40]  Clift,et al.  Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. , 1976, Blood.

[41]  V. Ferrans,et al.  ACUTE LETHAL CARDITIS CAUSED BY HIGH-DOSE COMBINATION CHEMOTHERAPY A Unique Clinical and Pathological Entity , 1976, The Lancet.

[42]  R. Aur,et al.  Cyclophosphamide‐induced hemorrhagic cystitis in children with leukemia , 1975, Cancer.

[43]  P. Neiman,et al.  High‐dose cyclophosphamide therapy for malignant disease. Toxicity, tumor response, and the effects of stored autologous marrow , 1972 .

[44]  R Storb,et al.  Technique for human marrow grafting. , 1970, Blood.

[45]  H. Skipper,et al.  Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia. , 1963, Cancer research.

[46]  H. Skipper,et al.  Experimental Evaluation of Potential Anticancer Agents: XII. Quantitative Drug Response of the SA180, CA755, and Leukemia L1210 Systems to a “Standard List” of “Active” and “Inactive” Agents , 1963 .

[47]  W. Dameshek,et al.  Autologous bone marrow infusion as an adjunct in therapy of malignant disease. , 1959, Blood.

[48]  O. Dalesio,et al.  Autologous bone marrow transplantation and solid tumors , 1984 .

[49]  S. Rapoport,et al.  Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors. , 1981, Cancer treatment reports.

[50]  H. Skipper,et al.  Concepts for controlling drug-resistant tumor cells. , 1980, European journal of cancer.

[51]  G. Zbinden.  Experimental and Clinical Aspects of Drug Toxicity , 1963 .